Skip to content

Urgent urology symptoms What to do

HER2-Targeted Therapy Challenges in Bladder Cancer Treatment

David Cohen, M.DPublished November 20, 20268 min read
HER2-Targeted Therapy Challenges in Bladder Cancer Treatment

Key points

  • A recent report from UroToday highlights the challenges in defining positivity for HER2-targeted therapy in bladder cancer.
  • HER2-targeted therapy works by interfering with the HER2 protein on the surface of cancer cells.
  • Defining HER2 positivity in bladder cancer is challenging because the criteria used in other cancers may not directly apply.
  • HER2-targeted therapy offers several potential benefits for bladder cancer patients.

What Is HER2-Targeted Therapy in Bladder Cancer?

A recent report from UroToday highlights the challenges in defining positivity for HER2-targeted therapy in bladder cancer. HER2, or human epidermal growth factor receptor 2, is a protein that can affect the growth of cancer cells. In some cancers, like breast cancer, targeting HER2 has been a successful strategy. This approach is still being explored for bladder cancer. HER2-targeted therapies aim to block this protein's action, potentially slowing cancer growth or shrinking tumors.

Bladder cancer is a significant health concern. It affects thousands each year, with men being more commonly affected than women. Traditional treatments include surgery, chemotherapy, and radiation. However, these treatments can sometimes be ineffective or come with significant side effects. Researchers are keen to find new, targeted treatments that might offer better outcomes with fewer side effects.

HER2-targeted therapy is not yet a standard treatment for bladder cancer. Early research suggests it might be beneficial for some patients. However, understanding which patients might benefit is complex. Not all bladder cancers express HER2, and the level of expression can vary. Defining positivity, or determining which cancers truly have HER2 as a driving force, is crucial for the success of targeted therapy.

How Does HER2-Targeted Therapy Work?

HER2-targeted therapy works by interfering with the HER2 protein on the surface of cancer cells. This protein can signal cancer cells to grow and divide rapidly. By blocking this signal, the therapy aims to stop or slow down the growth of the cancer. There are different types of HER2-targeted therapies, including monoclonal antibodies and tyrosine kinase inhibitors. These treatments can be used alone or in combination with other cancer therapies.

Monoclonal antibodies are lab-made molecules that can attach to the HER2 protein on cancer cells. This attachment can block the protein's action and mark the cancer cells for destruction by the immune system. Tyrosine kinase inhibitors, on the other hand, block the signals inside the cell that tell it to grow. Both types of therapies are designed to specifically target cancer cells, sparing normal cells and potentially reducing side effects.

The success of HER2-targeted therapy depends on accurately identifying patients who will benefit. This requires testing the cancer tissue to see if it has high levels of HER2. The challenge lies in defining what level of HER2 expression is considered positive. This decision can affect which patients receive the therapy and how well it works for them.

What Are the Challenges in Defining HER2 Positivity?

Defining HER2 positivity in bladder cancer is challenging because the criteria used in other cancers may not directly apply. In breast cancer, for example, well-established guidelines help determine HER2 status. These guidelines are based on specific criteria, such as the percentage of cells that express HER2 and the intensity of expression. In bladder cancer, these criteria are still being developed.

The variability in HER2 expression among bladder cancers adds another layer of complexity. Some tumors might have a high expression of HER2, while others have none, or the expression might be uneven within the same tumor. This variability makes it difficult to establish a one-size-fits-all criterion for positivity. Researchers are working to develop testing methods that can accurately reflect the HER2 status in bladder cancer.

Another challenge is the lack of standardization in testing methods. Different laboratories might use different tests or interpret results differently. This can lead to inconsistent results, making it hard to compare data across studies. Standardizing testing protocols and criteria for HER2 positivity is crucial for advancing HER2-targeted therapy in bladder cancer.

What Are the Potential Benefits of HER2-Targeted Therapy?

HER2-targeted therapy offers several potential benefits for bladder cancer patients. First, it provides a new treatment option for those who might not respond well to traditional therapies. By specifically targeting cancer cells with the HER2 protein, these therapies can potentially reduce tumor size and slow disease progression.

Another potential benefit is the reduction of side effects compared to traditional cancer treatments. Traditional methods like chemotherapy can affect both cancerous and healthy cells, leading to significant side effects. HER2-targeted therapies aim to minimize damage to healthy cells by focusing on the cancer cells' specific characteristics. This can lead to a better quality of life for patients during treatment.

Moreover, HER2-targeted therapies can be combined with other treatments to enhance their effectiveness. For example, they might be used alongside chemotherapy or immunotherapy. This combined approach can create a more robust attack on the cancer, potentially improving outcomes for patients. However, the success of these therapies depends on accurately identifying those who will benefit from them.

When Should You See a Doctor About Bladder Cancer?

If you experience any symptoms that could indicate bladder cancer, it’s important to see a doctor. Warning signs include blood in the urine (even if it’s just a small amount), frequent or urgent need to urinate, pain during urination, and lower back pain. These symptoms can be caused by various conditions, so it’s crucial to get a professional diagnosis.

There are also signs that require immediate medical attention. If you are unable to pass urine, experience severe pain in your side or back that comes with fever or vomiting, or notice a lot of blood or clots in your urine, seek urgent care. Similarly, sudden severe pain or swelling in a testicle, or fever with chills during a urinary infection, can be serious and need prompt treatment.

Early diagnosis and treatment are vital in managing bladder cancer. The sooner a potential cancer is identified, the better the chances of successful treatment. If you have any concerns or symptoms, don’t hesitate to talk to your doctor. They can guide you through the necessary tests and discuss potential treatment options if needed.

What Tests Are Used to Diagnose HER2 in Bladder Cancer?

Diagnosing HER2 in bladder cancer involves several tests. The most common method is immunohistochemistry (IHC), which uses antibodies to detect HER2 protein on the surface of cancer cells. This test provides information about the level of HER2 expression and helps categorize the cancer as HER2-positive or negative.

Another test is fluorescence in situ hybridization (FISH). This method looks at the cancer’s genetic material to see if there are extra copies of the HER2 gene. FISH is often used when IHC results are borderline or unclear. By examining the genetic level, FISH provides additional information that can confirm HER2 status.

Recently, newer techniques like next-generation sequencing (NGS) have been developed. These tests can provide a comprehensive overview of genetic changes in the cancer, including HER2 status. While not yet widely used for all cases, NGS represents a future direction for more precise and personalized cancer diagnostics.

What Are the Next Steps for Patients Considering HER2-Targeted Therapy?

If you or a loved one is considering HER2-targeted therapy for bladder cancer, the first step is to discuss it with your healthcare team. They can evaluate whether HER2 testing is appropriate and interpret the results. Understanding your HER2 status is crucial for determining if targeted therapy is a viable option.

Patients should also consider the potential benefits and risks of HER2-targeted therapy. While these therapies can offer new hope, they are not without side effects. Discussing these with your doctor can help you make an informed decision. They can also guide you on how this treatment fits into your overall cancer care plan.

Staying informed about ongoing research and clinical trials is also beneficial. As the understanding of HER2 in bladder cancer evolves, new therapies and strategies might become available. Participating in clinical trials can provide access to cutting-edge treatments and contribute to advancing medical knowledge. Always consult with your doctor to explore all available options and find the best approach for your individual situation.

Want to learn more? Read our guide to how the urinary system works and our overview of kidney stones.

Source: HER2-Targeted Therapy in Bladder Cancer and Challenges in Defining Positivity - Terence Friedlander (UroToday)

This article is for general information only and is not medical advice. Always talk with your doctor about your symptoms and treatment. If you cannot pass urine, have severe pain with fever, or have sudden testicle pain, call 911 or go to the nearest emergency room.

Frequently asked questions

What is HER2-targeted therapy in the context of bladder cancer?

HER2-targeted therapy focuses on treating bladder cancer by targeting the HER2 protein, which can promote cancer cell growth. This approach helps slow down or stop the progression of cancer. It is an evolving area of treatment that shows promise for certain patients.

How common is HER2 overexpression in bladder cancer?

HER2 overexpression occurs in a subset of bladder cancer cases. Not all bladder cancers have this characteristic, so testing is important. Knowing HER2 status helps doctors decide if HER2-targeted therapy is appropriate.

What challenges exist in using HER2-targeted therapy for bladder cancer?

Challenges include variability in HER2 expression and the potential for resistance to therapy. Some patients may not respond as hoped, and side effects can be an issue. Ongoing research aims to overcome these hurdles and improve outcomes.

Are there specific side effects associated with HER2-targeted therapies in bladder cancer?

Yes, side effects can vary depending on the specific medication used. Common issues may include fatigue, nausea, and heart-related concerns. It's important to discuss potential side effects with a healthcare provider.

How is HER2 status determined in bladder cancer patients?

Doctors use specific tests on tumor samples to determine HER2 status. These tests identify the presence and level of HER2 protein expression. Accurate testing is crucial for deciding on the best treatment strategy.

Can HER2-targeted therapy be combined with other treatments for bladder cancer?

Yes, it is often used alongside other treatments like chemotherapy or immunotherapy. Combining treatments can enhance effectiveness and improve patient outcomes. Your healthcare team will tailor the approach to your specific case.

Is HER2-targeted therapy a standard treatment for all bladder cancer patients?

No, it is not standard for all patients. It is specifically for those with HER2-positive bladder cancer. A healthcare provider will determine if this therapy is suitable based on individual test results.

What are the future directions for HER2-targeted therapy in bladder cancer?

Researchers are exploring new drugs and combination strategies to enhance the effectiveness of HER2-targeted therapy. Clinical trials are ongoing to find better ways to manage resistance and improve patient outcomes. The field is rapidly evolving with promising developments.

How do doctors decide if a patient should receive HER2-targeted therapy?

The decision is based on HER2 testing results and overall health status. Doctors consider the presence of HER2 overexpression and other individual factors. Open communication with your healthcare team is key to understanding your treatment options.

What role do clinical trials play in HER2-targeted therapy for bladder cancer?

Clinical trials are essential for testing new treatments and improving existing ones. They help determine the safety and effectiveness of HER2-targeted therapies. Participating in a trial can provide access to cutting-edge treatments under professional care.

Are there any alternative treatments if HER2-targeted therapy is not suitable?

Yes, there are other treatment options such as chemotherapy, surgery, and immunotherapy. Your healthcare provider will discuss alternative strategies if HER2-targeted therapy isn't appropriate. It's important to have a comprehensive treatment plan tailored to your needs.

When should someone with bladder cancer see a doctor about HER2-targeted therapy?

Consult a doctor if you have bladder cancer and want to explore HER2-targeted therapy options. Seek immediate medical attention or call 911 for urgent symptoms like inability to urinate, severe pain with fever, or sudden testicle pain. Early intervention is key to effective management.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.